Neuroprotective Potential of Origanum majorana L. Essential Oil Against Scopolamine-Induced Memory Deficits and Oxidative Stress in a Zebrafish Model

被引:1
作者
Brinza, Ion [1 ]
Boiangiu, Razvan Stefan [1 ]
Honceriu, Iasmina [1 ]
Abd-Alkhalek, Ahmed M. [2 ]
Osman, Samir M. [3 ]
Eldahshan, Omayma A. [4 ,5 ]
Todirascu-Ciornea, Elena [1 ]
Dumitru, Gabriela [1 ]
Hritcu, Lucian [1 ]
机构
[1] Alexandru Ioan Cuza Univ, Fac Biol, Dept Biol, Iasi 700506, Romania
[2] Al Azhar Univ, Fac Med Boys, Cairo 11651, Egypt
[3] October 6 Univ, Fac Pharm, Dept Pharmacognosy, Giza 3232031, Egypt
[4] Ain Shams Univ, Fac Pharm, Dept Pharmacognosy, Abbasiya 11566, Cairo, Egypt
[5] Ain Shams Univ, Ctr Drug Discovery Res & Dev, Cairo 11566, Egypt
关键词
ADMET; PASS Online; drug likeness; pKCSM; Origanum majorana essential oil; volatile oil; memory; anxiety; oxidative stress; Alzheimer's disease; dementia; scopolamine; Danio rerio; ALZHEIMERS-DISEASE; DRUG DISCOVERY; DANIO-RERIO; BRAIN; DISMUTASE; DYSFUNCTION; ANTIOXIDANT; PREDICTION; DEMENTIA; BEHAVIOR;
D O I
10.3390/biom15010138
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Origanum majorana L., also known as sweet marjoram, is a plant with multiple uses, both in the culinary field and traditional medicine, because of its major antioxidant, anti-inflammatory, antimicrobial, and digestive properties. In this research, we focused on the effects of O. majorana essential oil (OmEO, at concentrations of 25, 150, and 300 mu L/L), evaluating chemical structure as well as its impact on cognitive performance and oxidative stress, in both naive zebrafish (Danio rerio), as well as in a scopolamine-induced amnesic model (SCOP, 100 mu M). The fish behavior was analyzed in a novel tank-diving test (NTT), a Y-maze test, and a novel object recognition (NOR) test. We also investigated acetylcholinesterase (AChE) activity and the brain's oxidative stress status. In parallel, we performed in silico predictions (research conducted using computational models) of the pharmacokinetic properties of the main compounds identified in OmEO, using platforms such as SwissADME, pKCSM, ADMETlab 2.0, and ProTox-II. The results revealed that the major compounds were trans-sabinene hydrate (36.11%), terpinen-4-ol (17.97%), linalyl acetate (9.18%), caryophyllene oxide (8.25%), and alpha-terpineol (6.17%). OmEO can enhance memory through AChE inhibition, reduce SCOP-induced anxiety by increasing the time spent in the top zone in the NTT, and significantly reduce oxidative stress markers. These findings underscore the potential of using O. majorana to improve memory impairment and reduce oxidative stress associated with cognitive disorders, including Alzheimer's disease (AD).
引用
收藏
页数:37
相关论文
共 129 条
[31]   SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules [J].
Daina, Antoine ;
Michielin, Olivier ;
Zoete, Vincent .
SCIENTIFIC REPORTS, 2017, 7
[32]   Commentary: Establishing zebrafish as a model to study the anxiolytic effects of scopolamine [J].
de Abreu, Murilo S. ;
Friend, Ashton J. ;
Amstislavskaya, Tamara G. ;
Kalueff, Allan V. .
FRONTIERS IN PHARMACOLOGY, 2018, 9
[33]  
de la Torre Jack C, 2012, Cardiovasc Psychiatry Neurol, V2012, P367516, DOI 10.1155/2012/367516
[34]   A transdiagnostic examination of anxiety and stress on executive function outcomes in disorders with social impairment [J].
Demetriou, E. A. ;
Park, S. H. ;
Pepper, K. L. ;
Naismith, S. L. ;
Song, Y. J. ;
Thomas, E. E. ;
Hickie, I. B. ;
Guastella, A. J. .
JOURNAL OF AFFECTIVE DISORDERS, 2021, 281 :695-707
[35]   Alzheimer's Disease Pathology and Assistive Nanotheranostic Approaches for Its Therapeutic Interventions [J].
Dey, Anuvab ;
Ghosh, Subhrojyoti ;
Rajendran, Ramya Lakshmi ;
Bhuniya, Tiyasa ;
Das, Purbasha ;
Bhattacharjee, Bidyabati ;
Das, Sagnik ;
Mahajan, Atharva Anand ;
Samant, Anushka ;
Krishnan, Anand ;
Ahn, Byeong-Cheol ;
Gangadaran, Prakash .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (17)
[36]   Drug-Like Property Concepts in Pharmaceutical Design [J].
Di, Li ;
Kerns, Edward H. ;
Carter, Guy T. .
CURRENT PHARMACEUTICAL DESIGN, 2009, 15 (19) :2184-2194
[37]  
Dudhabhate B.B., 2023, 360-Degree Waste Management, Volume 2: Biomedical, Pharmaceutical, Industrial Waste, and Remediation, VVolume 2, P39, DOI [10.1016/B978-0-323-90909-9.00001-0, DOI 10.1016/B978-0-323-90909-9.00001-0, DOI 10.1016/B978-0-323-90909-9.00009-5]
[38]   Evaluation of Free Online ADMET Tools for Academic or Small Biotech Environments [J].
Dulsat, Julia ;
Lopez-Nieto, Blanca ;
Estrada-Tejedor, Roger ;
Borrell, Jose I. .
MOLECULES, 2023, 28 (02)
[39]   Understanding behavioral and physiological phenotypes of stress and anxiety in zebrafish [J].
Egan, Rupert J. ;
Bergner, Carisa L. ;
Hart, Peter C. ;
Cachat, Jonathan M. ;
Canavello, Peter R. ;
Elegante, Marco F. ;
Elkhayat, Salem I. ;
Bartels, Brett K. ;
Tien, Anna K. ;
Tien, David H. ;
Mohnot, Sopan ;
Beeson, Esther ;
Glasgow, Eric ;
Amri, Hakima ;
Zukowska, Zofia ;
Kalueff, Allan V. .
BEHAVIOURAL BRAIN RESEARCH, 2009, 205 (01) :38-44
[40]   Prediction of drug absorption using multivariate statistics [J].
Egan, WJ ;
Merz, KM ;
Baldwin, JJ .
JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (21) :3867-3877